---
figid: PMC6492912__CNS-22-431-g001
figtitle: The nicotinamide adenine dinucleotide (NAD) biosynthetic pathways in mammals
organisms:
- Homo sapiens
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC6492912
filename: CNS-22-431-g001.jpg
figlink: /pmc/articles/PMC6492912/figure/cns12539-fig-0001/
number: F1
caption: 'The nicotinamide adenine dinucleotide (NAD) biosynthetic pathways in mammals.
  There are two ways to maintain the cellular levels of NAD in mammals: the de novo
  pathway from tryptophan and the salvage pathway from NAM, NR, and NA with different
  catalyzing enzymes. NAMPT, the rate‐limiting enzyme of NAD synthesis in the salvage
  pathway, can be bound and upregulated by the two major circadian regulators, BMAL1
  and CLOCK, acting synergistically with SIRT1 , , , , , , , , , , , . BMAL1, aryl
  hydrocarbon receptor translocator‐like protein 1; CLOCK, circadian locomotor output
  cycles protein kaput; NA, nicotinic acid; NAD, nicotinamide adenine dinucleotide;
  NAM, nicotinamide; NAMN, nicotinic acid mononucleotide; NAMPT, nicotinamide phosphoribosyltransferase;
  NAPRT, nicotinic acid phosphoribosyltransferase; NMN, nicotinamide mononucleotide;
  NMNAT, nicotinamide mononucleotide adenylyltransferase; NR, nicotinamide riboside;
  NRK, nicotinamide ribose kinase; PARPs, poly‐ADP‐ribose polymerases; QAPRT, quinolinate
  phosphoribosyltransferase; SIRTs, sirtuins.'
papertitle: Targeting Nicotinamide Phosphoribosyltransferase as a Potential Therapeutic
  Strategy to Restore Adult Neurogenesis.
reftext: Shu‐Na Wang, et al. CNS Neurosci Ther. 2016 Jun;22(6):431-439.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.904975
figid_alias: PMC6492912__F1
figtype: Figure
redirect_from: /figures/PMC6492912__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6492912__CNS-22-431-g001.html
  '@type': Dataset
  description: 'The nicotinamide adenine dinucleotide (NAD) biosynthetic pathways
    in mammals. There are two ways to maintain the cellular levels of NAD in mammals:
    the de novo pathway from tryptophan and the salvage pathway from NAM, NR, and
    NA with different catalyzing enzymes. NAMPT, the rate‐limiting enzyme of NAD synthesis
    in the salvage pathway, can be bound and upregulated by the two major circadian
    regulators, BMAL1 and CLOCK, acting synergistically with SIRT1 , , , , , , , ,
    , , , . BMAL1, aryl hydrocarbon receptor translocator‐like protein 1; CLOCK, circadian
    locomotor output cycles protein kaput; NA, nicotinic acid; NAD, nicotinamide adenine
    dinucleotide; NAM, nicotinamide; NAMN, nicotinic acid mononucleotide; NAMPT, nicotinamide
    phosphoribosyltransferase; NAPRT, nicotinic acid phosphoribosyltransferase; NMN,
    nicotinamide mononucleotide; NMNAT, nicotinamide mononucleotide adenylyltransferase;
    NR, nicotinamide riboside; NRK, nicotinamide ribose kinase; PARPs, poly‐ADP‐ribose
    polymerases; QAPRT, quinolinate phosphoribosyltransferase; SIRTs, sirtuins.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NT5E
  - NRK
  - BMAL1
  - CLOCK
  - NMNAT1
  - CD38
  - STAC3
  - NAPRT
  - NAMPT
  - de
  - nr
  - na
  - Nrk
  - cyc
  - Clk
  - Nmnat
  - Naprt
  - Tryptophan
---
